Ji Yun Jung

Title(s)	Lecturer - Academic Year - 1/9, Literature
School	Vc-academic Affairs
Address	9500 Gilman Drive # La Jolla CA 92093
vCard	Download vCard

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Clinical utility of liver fat quantification for determining cardiovascular disease risk among patients with type 2 diabetes. Aliment Pharmacol Ther. 2023 Jul 11. Kuo SZ, Cepin S, Bergstrom J, Siddiqi H, Jung J, Lopez S, Huang DQ, Taub P, Amangurbanova M, Loomba R. PMID: 37431679.

View in: PubMed Mentions: Fields:
Dru Drug Therapy Gas Gastroenterology Pha Pharmacology
Translation:Humans
Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI-PDFF in NAFLD. Aliment Pharmacol Ther. 2023 Jul; 58(2):229-237. Kim BK, Bernstein N, Huang DQ, Tamaki N, Imajo K, Yoneda M, Sutter N, Jung J, Nguyen K, Nguyen L, Le T, Madamba E, Richards L, Valasek MA, Behling C, Sirlin CB, Nakajima A, Loomba R. PMID: 37269117; PMCID: PMC10330628.

View in: PubMed Mentions: Fields:
Dru Drug Therapy Gas Gastroenterology Pha Pharmacology
Translation:Humans
Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD. J Hepatol. 2022 12; 77(6):1482-1490. Kim BK, Tamaki N, Imajo K, Yoneda M, Sutter N, Jung J, Lin T, Tu XM, Bergstrom J, Nguyen K, Nguyen L, Le T, Madamba E, Richards L, Valasek MA, Behling C, Sirlin CB, Nakajima A, Loomba R. PMID: 35973577.

View in: PubMed Mentions: 7 Fields:
Gas Gastroenterology
Translation:Humans
English Fluency Is Not Enough: My Journey to Cultural Competency. J Cancer Educ. 2022 10; 37(5):1574-1576. Jung J. PMID: 35960474; PMCID: PMC9550740.

View in: PubMed Mentions: Fields:
Edu Education Neo Neoplasms
Translation:Humans
Direct Comparison of Quantitative US versus Controlled Attenuation Parameter for Liver Fat Assessment Using MRI Proton Density Fat Fraction as the Reference Standard in Patients Suspected of Having NAFLD. Radiology. 2022 07; 304(1):75-82. Jung J, Han A, Madamba E, Bettencourt R, Loomba RR, Boehringer AS, Andre MP, Erdman JW, O'Brien WD, Fowler KJ, Sirlin CB, Loomba R. PMID: 35348378; PMCID: PMC9270678.

View in: PubMed Mentions: 3 Fields:
Rad Radiology
Translation:Humans
Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: A prospective study. Aliment Pharmacol Ther. 2022 04; 55(7):820-827. Huang DQ, Fowler KJ, Liau J, Cunha GM, Louie AL, An JY, Bettencourt R, Jung J, Gitto Z, Hernandez C, Lopez SJ, Gupta H, Sirlin CB, Marks RM, Loomba R. PMID: 35229334.

View in: PubMed Mentions: 9 Fields:
Dru Drug Therapy Gas Gastroenterology Pha Pharmacology
Translation:Humans
Two-Step Strategy, FIB-4 Followed by Magnetic Resonance Elastography, for Detecting Advanced Fibrosis in NAFLD. Clin Gastroenterol Hepatol. 2023 02; 21(2):380-387.e3. Tamaki N, Imajo K, Sharpton SR, Jung J, Sutter N, Kawamura N, Yoneda M, Valasek MA, Behling C, Sirlin CB, Kurosaki M, Izumi N, Nakajima A, Loomba R. PMID: 35123096.

View in: PubMed Mentions: 2 Fields:
Gas Gastroenterology
Translation:Humans
Magnetic resonance elastography plus Fibrosis-4 versus FibroScan-aspartate aminotransferase in detection of candidates for pharmacological treatment of NASH-related fibrosis. Hepatology. 2022 03; 75(3):661-672. Tamaki N, Imajo K, Sharpton S, Jung J, Kawamura N, Yoneda M, Valasek MA, Behling C, Sirlin CB, Nakajima A, Loomba R. PMID: 34496054; PMCID: PMC9683538.

View in: PubMed Mentions: 8 Fields:
Gas Gastroenterology
Translation:Humans
Diagnostic accuracy of two-dimensional shear wave elastography and transient elastography in nonalcoholic fatty liver disease. Therap Adv Gastroenterol. 2021; 14:17562848211050436. Sharpton SR, Tamaki N, Bettencourt R, Madamba E, Jung J, Liu A, Behling C, Valasek MA, Loomba R. PMID: 34646360; PMCID: PMC8504217.

View in: PubMed Mentions: 7
Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-a realm for non-invasive testing. Authors' reply. Aliment Pharmacol Ther. 2021 07; 54(2):216. Park JG, Jung J, Loomba R. PMID: 34170539.

View in: PubMed Mentions: Fields:
Dru Drug Therapy Gas Gastroenterology Pha Pharmacology
Translation:Humans
Editorial: liver stiffness by magnetic resonance elastography and cardiovascular risk in non-alcoholic fatty liver disease-simply associated or more complicated? Authors' reply. Aliment Pharmacol Ther. 2021 06; 53(11):1230-1231. Park JG, Jung J, Loomba R. PMID: 33961702.

View in: PubMed Mentions: Fields:
Dru Drug Therapy Gas Gastroenterology Pha Pharmacology
Translation:Humans
Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease. Gut. 2022 05; 71(5):983-990. Tamaki N, Munaganuru N, Jung J, Yonan AQ, Loomba RR, Bettencourt R, Ajmera V, Valasek MA, Behling C, Sirlin CB, Loomba R. PMID: 33883248; PMCID: PMC8594562.

View in: PubMed Mentions: 13 Fields:
Gas Gastroenterology
Translation:Humans
Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2021 05; 53(9):1030-1037. Park JG, Jung J, Verma KK, Kang MK, Madamba E, Lopez S, Qas Yonan A, Liu A, Bettencourt R, Sirlin C, Loomba R. PMID: 33764550; PMCID: PMC8514119.

View in: PubMed Mentions: 10 Fields:
Dru Drug Therapy Gas Gastroenterology Pha Pharmacology
Translation:Humans
MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis. Gut. 2021 10; 70(10):1946-1953. Jung J, Loomba RR, Imajo K, Madamba E, Gandhi S, Bettencourt R, Singh S, Hernandez C, Valasek MA, Behling C, Richards L, Fowler K, Sirlin CB, Nakajima A, Loomba R. PMID: 33214165; PMCID: PMC8131405.

View in: PubMed Mentions: 29 Fields:
Gas Gastroenterology
Translation:Humans
Clinical Utility of Change in Nonalcoholic Fatty Liver Disease Activity Score and Change in Fibrosis in NAFLD. Clin Gastroenterol Hepatol. 2021 12; 19(12):2673-2674.e3. Tamaki N, Munaganuru N, Jung J, Yonan AQ, Bettencourt R, Ajmera V, Valasek MA, Behling C, Loomba R. PMID: 33157318; PMCID: PMC8438785.

View in: PubMed Mentions: 4 Fields:
Gas Gastroenterology
Translation:Humans